A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer

Published:2001-06 Issue:3 Volume:32 Page:281-287
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Zarogoulidis K.,Kontakiotis T.,Hatziapostolou P.,Fachantidou E.,Delis D.,Goutsikas J.,Constantinidis T.C.,Athanasiadis A.,Patakas D.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. First line treatment of non-small cell lung cancer with docetaxel and cisplatin. Preliminary results of a phase II study;Androulakis;Ann. Oncol.,1996

2. Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer;Belani;Semin. Oncol.,1995

3. Overview of taxotere-cisplatin (TXT/CDDP) combination in non-small lung cancer (NSCLC);Berille;Ann. Oncol.,1996

4. Bizzari JP. Docetaxel PR 56976. Integrated summary. Advanced or metastatic non-small-cell-lung cancer, 16 July 1994 (Data on file, Rhone-Poulenc Rorer).

5. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group;Bonomi;J. Clin. Oncol.,1989

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review;Translational Lung Cancer Research;2021-01

2. Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer;Oncology Letters;2017-01-18

3. A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer;J THORAC DIS;2014

4. “One-stop shop” spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology;International Journal of Nanomedicine;2013-11

5. Treatment of non-small cell lung cancer (NSCLC);J THORAC DIS;2013